dacarbazine and Adrenocortical Carcinoma

dacarbazine has been researched along with Adrenocortical Carcinoma in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Creemers, SG; de Herder, WW; Feelders, RA; Franssen, GJ; Hofland, LJ; Korpershoek, E; van den Dungen, ES; van Kemenade, FJ; van Koetsveld, PM1

Other Studies

1 other study(ies) available for dacarbazine and Adrenocortical Carcinoma

ArticleYear
Inhibition of Human Adrenocortical Cancer Cell Growth by Temozolomide in Vitro and the Role of the MGMT Gene.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:12

    Topics: Adolescent; Adrenal Cortex Neoplasms; Adrenocortical Carcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Cell Line, Tumor; Child; Dacarbazine; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Mitotane; Promoter Regions, Genetic; RNA, Messenger; Temozolomide; Tumor Cells, Cultured; Tumor Suppressor Proteins; Young Adult

2016